Reducing the risk of peripherally inserted central catheter line complications in the oncology setting

European Journal of Cancer Care

Volumn 15, Issue 4, 2006, Pages 342-347

  Yap, Y S ^a   Karapetis, C ^a   Lerose, S ^a   Iyer, S ^a   Koczwara, B ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Chemotherapy; Peripherally inserted central catheter (PICC)

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CATHETERIZATION; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CATHETERIZATION, PERIPHERAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33748487200     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2006.00664.x     Document Type: Article

References (13)

1. Cardella J.F., Cardella K., Bacci N., Fox P.S. & Post J.H. (1996) Cumulative experience with 1273 peripherally inserted central catheters at a single institution. Journal of Vascular and Interventional Radiology 7, 5-13.
2. Cheong K., Perry D., Karapetis C. & Koczwara B. (2004) High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours. Internal Medicine Journal 34, 234-238.
3. Hamory B.H., Pearson S.K. & Duffy K.R. (1984) Efficacy of professional i.v. therapy teams in reducing complications of i.v. cannulae. In: Abstracts of the 84th Annual Meeting of the American Society for Microbiology, 4-9 March 1984, St Louis, Missouri, 307. American Society for Microbiology, Washington, DC, USA.
4. Klerk C.P.W., Smorenburg S.M. & Buller H.R. (2003) Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Archives of Internal Medicine 163, 1913-1921.
5. Last K.W., Mansi J.L., Oakley C. & Lofts F.J. (1998) Long term intravenous access devices: superiority of peripherally inserted central cannulae (PICCs) over Hickman Catheters (HCs). Annals of Oncology 9 (Suppl. 4), 142 [Abstract].
6. Maki D.G., Ringer M. & Alvarado C.J. (1991) Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338, 339-343.
7. Mermel L.A. (2002) Prevention of intravascular catheter-related infections. Annals of Internal Medicine 132, 391-402.
8. Ng P., Ault M.J., Ellrodt A.G. & Maldonado L. (1997) Peripherally inserted central catheters in general medicine. Mayo Clinic Proceedings 72, 225-233.
9. O'Grady N.P., Alexander M., Dellinger E.P., Gerberding J.L., Heard S.O., Maki D.G., Masur H., McCormick R.D., Mermel L.A., Pearson M.L., Raad I.I., Randolph A., Weinstein R.A. & Healthcare Infection Control Practices Advisory Committee (2002) Guidelines for the prevention of intravascular catheterrelated infections. American Journal of Infection Control 30, 476-489.
10. Smith J.R., Friedell M.L., Cheatham M.L., Martin S.P., Cohen M.J. & Horowitz J.D. (1998) Peripherally inserted central catheters revisited. The American Journal of Surgery 176, 208-211.
11. Soifer N.E., Borzak S., Edlin B.R. & Weinstein R.A. (1998) Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomised controlled study. Archives of Internal Medicine 15, 473-477.
12. Tesselaar M., Ouwerkerk J., Rosendaal F.R. & Osanto S. (2001) Prophylaxis with low molecular weight heparin reduces the risk for catheter-related venous thrombosis in cancer patients with centrally but not peripherally inserted central venous catheters for administration of chemotherapy. European Journal of Cancer 37 (Suppl. 6), S354 [Abstract 1319].
13. Walshe L.J., Malak S.F., Eagan J. & Sepkowitz K.A. (2002) Complication rates among cancer patients with peripherally inserted central catheters. Journal of Clinical Oncology 20, 3276-3281.